Biomarkers and biomarker validation: a pathologist's guide to getting it right

American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz et al. · Journal of Clinical Oncology · 2006 · 4.5K citations · Full text

Medicine, Oncology, Pathology +11

Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update

Antonio C. Wolff, M. Elizabeth Hammond, Kimberly H. Allison et al. · Journal of Clinical Oncology · 2018 · 2.5K citations · Full text

Medicine, Oncology, Pathology +15

Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and <i>RAS</i> Mutations in Colorectal Cancer

Eric Van Cutsem, Heinz‐Josef Lenz, Claus-Henning Köhne et al. · Journal of Clinical Oncology · 2015 · 800 citations · Full text

Medicine, Oncology, Pharmacology +17

Mutation in the Tyrosine Kinase Domain of Epidermal Growth Factor Receptor Is a Predictive and Prognostic Factor for Gefitinib Treatment in Patients with Non–Small Cell Lung Cancer

Teh‐Ying Chou, Chao‐Hua Chiu, Ling‐Hui Li et al. · Clinical Cancer Research · 2005 · 322 citations

Medicine, Oncology, Pharmacology +16

Principles of Analytic Validation of Immunohistochemical Assays: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center

Patrick L. Fitzgibbons, Linda Bradley, Lisa A. Fatheree et al. · Archives of Pathology & Laboratory Medicine · 2014 · 282 citations

Medicine, Pathology, Cellular Pathology +16